Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688076.SS.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and...
Can you invest in Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.?
Yes. Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688076.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.